Treatment with Torin (inhibitor of mTORC1 and mTORC2) resulted in significant reduction p‐AKT (S473) in tumour‐conditioned microglia (Figs 2F and EV1A), a finding which was validated by FACS (Figs 2G and EV1B and F). This evidence concerns the gene AKT1 and neoplasm.